Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

The following is a summary of “Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1,” published in the March 2025 issue of ...

Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...

Less than a quarter of patients diagnosed with mild psoriasis had a body surface area of less than 3% at the time of diagnosis.

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel, March ...

Citing Neal’s Yard Remedies’ hair treatment as “great for managing symptoms,” Maguire enjoys how the included rosemary, ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...